We are live on ! Find out more
ALT icon

Altimmune
ALT

88 hedge funds and large institutions have $231M invested in Altimmune in 2020 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 21

69% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 16

22% more funds holding

Funds holding: 72 → 88 (+16)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4.73% less ownership

Funds ownership: 66.54% → 61.81% (-4.7%)

19% less capital invested

Capital invested by funds: $285M → $231M (-$54.8M)

22% less call options, than puts

Call options by funds: $5.2M | Put options by funds: $6.7M

Holders
88
Holders Change
+16
Holders Change %
+22.22%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
37
Increased
27
Reduced
16
Closed
21
Calls
$5.2M
Puts
$6.7M
Net Calls
-$1.5M
Net Calls Change
-$2.58M

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$16.5M
2
CS
Credit Suisse
Switzerland
+$14.1M
3
Citadel Advisors
Citadel Advisors
Florida
+$7.83M
4
Capital World Investors
Capital World Investors
California
+$6.4M
5
BlackRock
BlackRock
New York
+$5.84M

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$26.4M
2
AC
Armistice Capital
New York
-$19M
3
RI
RTW Investments
New York
-$17.6M
4
Renaissance Technologies
Renaissance Technologies
New York
-$13.5M
5
Two Sigma Investments
Two Sigma Investments
New York
-$7.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$851K +$114K +9,704 +15%
Qube Research & Technologies (QRT)
27
Qube Research & Technologies (QRT)
United Kingdom
$839K +$701K +59,469 +399%
CSS
28
Cubist Systematic Strategies
Connecticut
$836K +$7.28K +618 +0.8%
HS
29
HighVista Strategies
Massachusetts
$816K +$853K +72,378 New
Morgan Stanley
30
Morgan Stanley
New York
$753K +$465K +39,429 +144%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$677K +$64.2K +5,448 +10%
AA
32
ALPS Advisors
Colorado
$671K +$701K +59,475 New
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$650K -$14.1K -1,200 -2%
PAM
34
Premier Asset Management
Illinois
$627K +$655K +55,576 New
KCM
35
Knoll Capital Management
Florida
$564K +$589K +50,000 New
PC
36
PointState Capital
New York
$564K +$589K +50,000 New
Goldman Sachs
37
Goldman Sachs
New York
$528K -$101K -8,598 -16%
Thrivent Financial for Lutherans
38
Thrivent Financial for Lutherans
Minnesota
$512K +$535K +45,439 New
HR
39
Hayden Royal
North Carolina
$501K +$141K +12,000 +37%
GCP
40
GSA Capital Partners
United Kingdom
$484K +$506K +42,925 New
T. Rowe Price Associates
41
T. Rowe Price Associates
Maryland
$462K +$290K +24,600 +150%
Two Sigma Investments
42
Two Sigma Investments
New York
$461K -$7.2M -611,316 -94%
JF
43
Jump Financial
Illinois
$414K -$234K -19,900 -35%
BRWA
44
B. Riley Wealth Advisors
Florida
$369K +$385K +32,650 New
6CM
45
683 Capital Management
New York
$369K +$385K +32,678 New
Marshall Wace
46
Marshall Wace
United Kingdom
$350K +$366K +31,049 New
Jane Street
47
Jane Street
New York
$348K +$363K +30,825 New
Barclays
48
Barclays
United Kingdom
$319K +$1.18K +100 +0.4%
BCM
49
Bridgeway Capital Management
Texas
$314K -$58.9K -5,000 -15%
MIG
50
McGuire Investment Group
Rhode Island
$303K +$317K +26,905 New
1
2
3 4 5

ALT Hedge Fund Activity: Q4 2020 in Review

88 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q4 2020, worth a combined $231M — down 19% from $285M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new ALT positions and 21 closed out — a net gain of 16 holders — while 27 added to existing stakes and 16 trimmed.

The largest buyer was UBS Group, adding an estimated $16.5M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $26.4M sold.

  • 88 institutional investors held Altimmune (ALT) as of Q4 2020, up from 72 in Q3 2020.
  • Funds reported $231M of Altimmune stock for Q4 2020, down 19% quarter-over-quarter.
  • 37 funds opened new Altimmune positions in Q4 2020 and 21 closed out, a net change of +16 holders.
  • The largest Altimmune buyer in Q4 2020 was UBS Group, an estimated $16.5M added.
  • The largest Altimmune seller in Q4 2020 was Avoro Capital Advisors, an estimated $26.4M sold.

Based on aggregated 13F filings for Q4 2020.